宫内生长受限和小于胎龄复杂妊娠中的母体血浆标志物：可溶性血管内皮生长因子受体-1/胎盘生长因子的作用 - Suppr | 超能文献

Maternal plasma markers in intrauterine growth restriction and small for gestational age complicated pregnancy: the role of sFlt-1/PlGF.

作者信息

Libretti Alessandro, Valsecchi Luca, Zerbini Gianpaolo, Remorgida Valentino, Candiani Massimo

机构信息

Department of Gynecology and Obstetrics, AOU Maggiore della Carità, Novara, Italy -

School of Gynecology and Obstetrics, University of Eastern Piedmont, Novara, Italy -

出版信息

Minerva Obstet Gynecol. 2023 Dec;75(6):588-589. doi: 10.23736/S2724-606X.23.05384-8. Epub 2023 Aug 4.

DOI:10.23736/S2724-606X.23.05384-8

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Maternal plasma markers in intrauterine growth restriction and small for gestational age complicated pregnancy: the role of sFlt-1/PlGF.宫内生长受限和小于胎龄复杂妊娠中的母体血浆标志物：可溶性血管内皮生长因子受体-1/胎盘生长因子的作用

Minerva Obstet Gynecol. 2023 Dec;75(6):588-589. doi: 10.23736/S2724-606X.23.05384-8. Epub 2023 Aug 4.

2

Role of sFlt-1 and PlGF in the screening of small-for-gestational age neonates during pregnancy: A systematic review.可溶性血管内皮生长因子受体-1和胎盘生长因子在孕期小于胎龄儿筛查中的作用：一项系统评价

Ann Clin Biochem. 2020 Jan;57(1):44-58. doi: 10.1177/0004563219882042. Epub 2019 Nov 23.

3

Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.可溶性 fms 样酪氨酸激酶与胎盘生长因子比值在不同时期的胎儿生长受限及小于胎龄儿中的变化。

Acta Obstet Gynecol Scand. 2021 Jan;100(1):119-128. doi: 10.1111/aogs.13978. Epub 2020 Sep 14.

4

The sFlt-1/PlGF ratio values within the <38, 38-85 and >85 brackets as compared to perinatal outcomes.sFlt-1/PlGF 比值在<38、38-85 和>85 范围内与围产结局的比较。

J Perinat Med. 2019 Sep 25;47(7):732-740. doi: 10.1515/jpm-2019-0019.

5

Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.小于胎龄儿的预测：孕30 - 34周时通过生物物理和生化标志物进行筛查。

Ultrasound Obstet Gynecol. 2015 Oct;46(4):446-51. doi: 10.1002/uog.14863. Epub 2015 Aug 6.

6

Intrauterine growth restriction, soluble fms-like tyrosine kinase-1 to placental growth factor ratio increase and preeclampsia.宫内生长受限、可溶性fms样酪氨酸激酶-1与胎盘生长因子比值升高及子痫前期。

J Gynecol Obstet Hum Reprod. 2019 Oct;48(8):695-697. doi: 10.1016/j.jogoh.2019.05.007. Epub 2019 May 11.

7

An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia.可溶性血管内皮生长因子受体-1（sFlt-1）与胎盘生长因子（PlGF）的比值为655时，并非预测子痫前期女性围产期结局的可靠临界值。

Pregnancy Hypertens. 2018 Jan;11:54-60. doi: 10.1016/j.preghy.2018.01.001. Epub 2018 Jan 2.

8

Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.母体循环中的血管生成因子与子痫前期及其与胎儿生长受限的关系。

Acta Obstet Gynecol Scand. 2012 Dec;91(12):1388-94. doi: 10.1111/j.1600-0412.2012.01516.x. Epub 2012 Oct 17.

9

Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.早期妊娠中的循环血管生成因子与子痫前期、胎儿生长受限、自发性早产和死产的风险

Obstet Gynecol. 2007 Jun;109(6):1316-24. doi: 10.1097/01.AOG.0000265804.09161.0d.

10

Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.sFlt-1 和 PlGF 在子痫前期和胎儿生长受限的筛查、预测、诊断和监测中的临床应用。

Ultrasound Obstet Gynecol. 2023 Feb;61(2):168-180. doi: 10.1002/uog.26032.

引用本文的文献

1

Exploring the health complications of female genital mutilation through a systematic review and meta-analysis.通过系统评价和荟萃分析探究女性生殖器切割的健康并发症。

BMC Public Health. 2025 Apr 14;25(1):1387. doi: 10.1186/s12889-025-21584-z.